Terms: = Endocrine gland cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
18 results:
1. lrp1b-a prognostic marker in tubo-ovarian high-grade serous carcinoma.
Kolb S; Hoffmann I; Monjé N; Dragomir MP; Jank P; Bischoff P; Keunecke C; Pohl J; Kunze CA; Marchenko S; Schmitt WD; Kulbe H; Sers C; Sehouli J; Braicu EI; Denkert C; Darb-Esfahani S; Horst D; Sinn BV; Taube ET
Hum Pathol; 2023 Nov; 141():158-168. PubMed ID: 37742945
[TBL] [Abstract] [Full Text] [Related]
2. Chromosome instability region analysis and identification of the driver genes of the epithelial ovarian cancer cell lines A2780 and SKOV3.
Li J; Chen Z; Xiao W; Liang H; Liu Y; Hao W; Zhang Y; Wei F
J Cell Mol Med; 2023 Nov; 27(21):3259-3270. PubMed ID: 37525498
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-196a-5p targeting lrp1b modulates phenotype of thyroid carcinoma cells.
Hu Y; Zhang C; Chang Q; Du J; Lu H; Guo X; Chang W; Liu S; Chen C
Endokrynol Pol; 2023; 74(2):144-152. PubMed ID: 36916542
[TBL] [Abstract] [Full Text] [Related]
4. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract] [Full Text] [Related]
5. lrp1b Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian cancer.
Dionísio de Sousa IJ; Cunha AI; Saraiva IA; Portugal RV; Gimba ERP; Guimarães M; Prazeres H; Lopes JM; Soares P; Lima RT
Pathobiology; 2021; 88(6):400-411. PubMed ID: 34689147
[TBL] [Abstract] [Full Text] [Related]
6. Targeted genomic analysis of 364 adrenocortical carcinomas.
Pozdeyev N; Fishbein L; Gay LM; Sokol ES; Hartmaier R; Ross JS; Darabi S; Demeure MJ; Kar A; Foust LJ; Koc K; Bowles DW; Leong S; Wierman ME; Kiseljak-Vassiliades K
Endocr Relat Cancer; 2021 Aug; 28(10):671-681. PubMed ID: 34410225
[TBL] [Abstract] [Full Text] [Related]
7. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
[TBL] [Abstract] [Full Text] [Related]
8. Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian
Shen W; Shan B; Liang S; Zhang J; Yu Y; Zhang Y; Wang G; Bai Y; Qian B; Lu J; Jiang Z
Pathol Oncol Res; 2021; 27():581534. PubMed ID: 34257528
[No Abstract] [Full Text] [Related]
9. A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.
Zhang Y; Shi X; Zhang J; Chen X; Zhang P; Liu A; Zhu T
Sci Rep; 2021 Jan; 11(1):387. PubMed ID: 33432021
[TBL] [Abstract] [Full Text] [Related]
10. Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases.
Hlavac V; Mohelnikova-Duchonova B; Lovecek M; Ehrmann J; Brynychova V; Kolarova K; Soucek P
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33255265
[TBL] [Abstract] [Full Text] [Related]
11. Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3.
Konukiewitz B; Jesinghaus M; Steiger K; Schlitter AM; Kasajima A; Sipos B; Zamboni G; Weichert W; Pfarr N; Klöppel G
Hum Pathol; 2018 Jul; 77():70-79. PubMed ID: 29596894
[TBL] [Abstract] [Full Text] [Related]
12. Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
Maru Y; Tanaka N; Ohira M; Itami M; Hippo Y; Nagase H
Gynecol Oncol; 2017 Feb; 144(2):377-383. PubMed ID: 27939411
[TBL] [Abstract] [Full Text] [Related]
13. A robust biomarker of differential correlations improves the diagnosis of cytologically indeterminate thyroid cancers.
Gomez-Rueda H; Palacios-Corona R; Gutiérrez-Hermosillo H; Trevino V
Int J Mol Med; 2016 May; 37(5):1355-62. PubMed ID: 27035928
[TBL] [Abstract] [Full Text] [Related]
14. Association between Variants in Atopy-Related Immunologic Candidate Genes and Pancreatic cancer Risk.
Cotterchio M; Lowcock E; Bider-Canfield Z; Lemire M; Greenwood C; Gallinger S; Hudson T
PLoS One; 2015; 10(5):e0125273. PubMed ID: 25945796
[TBL] [Abstract] [Full Text] [Related]
15. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract] [Full Text] [Related]
16. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.
Arnesen T; Glomnes N; Strømsøy S; Knappskog S; Heie A; Akslen LA; Grytaas M; Varhaug JE; Gimm O; Brauckhoff M
Langenbecks Arch Surg; 2013 Aug; 398(6):869-74. PubMed ID: 23778974
[TBL] [Abstract] [Full Text] [Related]
17. lrp1b deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.
Cowin PA; George J; Fereday S; Loehrer E; Van Loo P; Cullinane C; Etemadmoghadam D; Ftouni S; Galletta L; Anglesio MS; Hendley J; Bowes L; Sheppard KE; Christie EL; Pearson RB; Harnett PR; Heinzelmann-Schwarz V; Friedlander M; McNally O; Quinn M; Campbell P; deFazio A; Bowtell DD;
Cancer Res; 2012 Aug; 72(16):4060-73. PubMed ID: 22896685
[TBL] [Abstract] [Full Text] [Related]
18. Chromosomal, epigenetic and microRNA-mediated inactivation of lrp1b, a modulator of the extracellular environment of thyroid cancer cells.
Prazeres H; Torres J; Rodrigues F; Pinto M; Pastoriza MC; Gomes D; Cameselle-Teijeiro J; Vidal A; Martins TC; Sobrinho-Simões M; Soares P
Oncogene; 2011 Mar; 30(11):1302-17. PubMed ID: 21057533
[TBL] [Abstract] [Full Text] [Related]
